David Lewis
NCRI UK · Imperial College London · University of Surrey
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Lewis as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:35 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04802590 · Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell LymphomaThe Lymphoma Academic Research Organisation · active not recruiting · Mantle Cell Lymphoma · principal investigator
- Ph1NCT03408262 · Clinical Trial of HIV Vaccine Combinations in Healthy Men and WomenImperial College London · completed · Human Immunodeficiency Virus · principal investigator
- Ph1NCT02589795 · Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy VolunteersImperial College London · completed · HIV · principal investigator
- N/ANCT02557802 · T-cell Diversity Following Intranasal and Intramuscular VaccinesUniversity of Surrey · completed · Influenza · principal investigator
- N/ANCT02556047 · Evaluation of the Safety & Performance of 2 Intradermal Safety DevicesUniversity of Surrey · completed · Syringe · principal investigator
- N/ANCT01771367 · Training Study to Characterize Biomarkers to Flu VaccinesUniversity of Surrey · completed · Healthy · principal investigator
- N/ANCT01578148 · Noxipoint Therapy Versus Standard Physical Therapy Using Electrical Stimulation for Chronic PainPain Cure Center, California · completed · Shoulder Pain, Neck Pain · principal investigator
- N/ANCT00623051 · Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)French National Agency for Research on AIDS and Viral Hepatitis · completed · HIV Infections · principal investigator
- Ph2NCT00210288 · Healthy Adult Volunteer Study for Two Doses of a Shigella VaccineInstitut Pasteur · completed · Shigella Infection · principal investigator
- Ph2/Ph3NCT00164424 · Episodic Acyclovir Therapy for Genital UlcersCenters for Disease Control and Prevention · completed · HIV Infections, Ulcer, Herpes Simplex · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 36 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Training Program in Adult and Pediatric RheumatologyT32AR050942 · NIAMS · STANFORD UNIVERSITY · fiscal years 2020 to 2025 · $331,817 awarded in 2025Same name and institution; not confirmed by an ID
- Transitional and Naive CD4 T cells and B cells in Infant Vaccine ResponsesR01AI100121 · NIAID · STANFORD UNIVERSITY · fiscal years 2012 to 2016 · $350,919 awarded in 2016Same name and institution; not confirmed by an ID
- Recent Thymic Emigrants of the CD4 T-cell LineageR01AI083757 · NIAID · STANFORD UNIVERSITY · fiscal years 2010 to 2014 · $403,698 awarded in 2014Same name and institution; not confirmed by an ID
- Leukocyte Signaling in the Elderly and Vaccine ImmunogenicityR01AI093625 · NIAID · STANFORD UNIVERSITY · fiscal years 2010 to 2012 · $396,000 awarded in 2012Same name and institution; not confirmed by an ID
- Recent Thymic Emigrants of the CD4 T-cell LineageR56AI083757 · NIAID · STANFORD UNIVERSITY · fiscal years 2009 · $240,726 awarded in 2009Same name and institution; not confirmed by an ID
- Educational ComponentU19AI057229 · NIAID · STANFORD UNIVERSITY · fiscal years 2008 · $101,576 awarded in 2008Same name and institution; not confirmed by an ID
- Granulysin: A Novel Cytolytic MoleculeR01AI043348 · NIAID · STANFORD UNIVERSITY · fiscal years 2006 · $308,584 awarded in 2006Same name and institution; not confirmed by an ID
- Postnatal ontogeny of HCMV-specific CD4 T cell immunityP01AI048212 · NIAID · STANFORD UNIVERSITY · fiscal years 2000 to 2003 · $187,449 awarded in 2003Same name and institution; not confirmed by an ID
- VIRAL INDUCED COSTIMULATORY MOLECULES AND ASTHMAR01AI044699 · NIAID · STANFORD UNIVERSITY · fiscal years 1998 to 2001 · $313,286 awarded in 2001Same name and institution; not confirmed by an ID
- REDUCED CYTOKINE PRODUCTION BY NEONATAL T CELLSR01HD036291 · NICHD · STANFORD UNIVERSITY · fiscal years 1997 to 2000 · $255,753 awarded in 2000Same name and institution; not confirmed by an ID
- DIFFERENTIAL GENE EXPRESSION BY T CELLS AND THYMOCYTESR21HD037589 · NICHD · STANFORD UNIVERSITY · fiscal years 1998 to 1999 · $171,820 awarded in 1999Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:35 UTC. The ranking covers the 200 most relevant of 271 PubMed records, and a shared surname and initials can bring in a namesake. All 271 on PubMed
- 1,891 citationsRCR 57.6
- Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.J Clin Oncol · 2023529 citationsRCR 47.7
- 524 citationsRCR 18.0
- Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.Lancet · 2021399 citationsRCR 21.4
- 369 citationsRCR 9.5
- 301 citationsRCR 15.0
- 284 citationsRCR 42.7
- 252 citationsRCR 6.3
- Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.Lancet Oncol · 2015242 citationsRCR 9.2
- Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia.Am J Psychiatry · 2008240 citationsRCR 6.4